May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
The Predictive Accuracy of the One-Eyed Trial in the Ocular Hypertension Treatment Study (OHTS)
Author Affiliations & Notes
  • A. M. Bhorade
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • B. S. Wilson
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • P. Palmberg
    Ophthalmology and Visual Sciences, Bascom Palmer Eye Institute, University of Miami, Miami, Florida
  • E. Miller
    Ophthalmology and Visual Sciences, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania
  • R. T. Chang
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • M. A. Kass
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • M. O. Gordon
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • Ocular Hypertension Treatment Study Group
    Ophthalmology and Visual Sciences, Washington University, Saint Louis, Missouri
  • Footnotes
    Commercial Relationships A.M. Bhorade, None; B.S. Wilson, None; P. Palmberg, None; E. Miller, Alcon, Allergan, C; R.T. Chang, None; M.A. Kass, Allergan, Pfizer, F; Pfizer, C; Pfizer, R; M.O. Gordon, None.
  • Footnotes
    Support NIH Grants EY 09307, EY 09341, EY015498, National Center on Minority Health and Health Disparities, Merck Research Laboratories; Pfizer, Inc. and an unrestricted grant from Research to Prevent Blindne
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 5555. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. M. Bhorade, B. S. Wilson, P. Palmberg, E. Miller, R. T. Chang, M. A. Kass, M. O. Gordon, Ocular Hypertension Treatment Study Group; The Predictive Accuracy of the One-Eyed Trial in the Ocular Hypertension Treatment Study (OHTS). Invest. Ophthalmol. Vis. Sci. 2007;48(13):5555.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To determine how accurately the intraocular pressure (IOP) response in a one-eyed therapeutic trial in the first eye predicts the IOP response of the second eye in OHTS.

 
Methods:
 

Of 817 participants randomized to medication, we report on 590 participants who completed a one-eyed trial using a topical beta-blocker medication. Baseline IOPs were the untreated IOPs for both eyes prior to randomization. The post-treatment IOP in the first eye was the IOP after approximately 4-6 weeks of treatment. The post-treatment IOP in the second eye was the IOP after approximately 5 months of treatment. A Pearson partial correlation coefficient adjusting for age, central corneal thickness, time on treatment, and other factors, was calculated to determine the association between the IOP response in the first eye and the second eye.

 
Results:
 

Pearson partial correlation coefficient between post-treatment IOPs in the first and second eye is 0.43, (p<0.0001).  

 
Conclusions:
 

Recently, the validity of the therapeutic one-eyed trial in clinical practice has been called into question. The results in OHTS suggest that there is a moderate correlation between the response of the first and second eyes of a patient to topical beta blockers.

 
Clinical Trial:
 

www.clinicaltrials.gov NCT00000125

 
Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×